Eoseb-S 375 Injection
Marketer
Sebert Lifesciences
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Eoseb-S 375 Injection
Eoseb-S 375 Injection, a combined medication, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be overseen by a medical professional. Strict adherence to the prescribed treatment schedule is crucial; premature cessation can compromise efficacy. Complete the full course, even with symptom improvement. Common adverse reactions include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) demand prompt medical help. Inform your physician of all concurrent medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing to driving ability, drowsiness or dizziness warrants driving cessation. Adequate rest, a nutritious diet, and sufficient hydration are vital for optimal recovery. Your doctor may order tests to monitor treatment effectiveness.
Uses of Eoseb-S 375 Injection
Infections caused by bacteria
Major Benefits of Eoseb-S 375 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Eoseb-S 375 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Eoseb-S 375 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Eoseb-S 375 Injection works:
Ceftriaxone and Sulbactam, combined as Eoseb-S 375 Injection, offer a targeted antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Eoseb-S 375 Injection can be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Eoseb-S 375 is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, data from human clinical trials remain scarce.
Breast feedingCAUTION
Administering Eoseb-S 375 Injection to breastfeeding mothers requires careful consideration. Breastfeeding should be discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Eoseb-S 375 Injection could lead to drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Eoseb-S 375 Injection's use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Individuals with severe hepatic impairment should use Eoseb-S 375 Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Dosage alteration for Eoseb-S 375 Injection is unnecessary in patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Eoseb-S 375 Injection :
Omitting a scheduled dose of Eoseb-S 375 Injection necessitates contacting your physician.
Facts to Know About Eoseb-S 375 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently